source
- Ipsen to acquire Memo Therapeutics and its kidney infection candidateFrench drugmaker Ipsen announced a new acquisition, agreeing to buy Memo Therapeutics along with its experimental kidney infection drug. This marks Ipsen's second transaction announced within a wee…
- STAT+: More signs that GLP-1s may help with peripheral artery diseaseAnthropic will begin developing drugs, BridgeBio pockets a billion, and more biotech news from The Readout